Eczema Clinical Trial - 8-Week Atopic Dermatitis (AD) Treatment Study

Status Completed

Clinical Trial Summary

This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).

Clinical Trial Description

This will be a 9-week, randomized, double blind, parallel comparison study consisting of a 1-week washout phase followed by an 8-week treatment phase. This study will be executed by one clinical research company utilizing two test sites and up to 62 subjects with moderate or severe atopic dermatitis, ages 12-65, will be enrolled. Subjects that are enrolled will be placed on one of three products (e.g. Sponsor's Experimental Cream Treatment, a basic moisturizer, or a positive control - Desonide) and will be required to use the assigned product twice a day for the duration of the 8-week treatment phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03386032
Study type	Interventional
Source	Procter and Gamble
Contact
Status	Completed
Phase	Phase 3
Start date	November 27, 2017
Completion date	August 18, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05579899` - Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis	Phase 2
Terminated	`NCT04085549` - Effects of a Berry Oil Cream on Atopic Eczema and Skin	N/A
Recruiting	`NCT05578482` - Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis	Phase 4
Completed	`NCT03540043` - Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis	Phase 2
Recruiting	`NCT03293030` - Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis	Phase 4
Completed	`NCT03667014` - The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients	Phase 4
Terminated	`NCT05382819` - A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis	Phase 1
Completed	`NCT04537468` - Development of a Method to Measure mRNA Levels in Skin Samples	N/A
Completed	`NCT03268174` - Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.	N/A
Active, not recruiting	`NCT03859986` - Study in Subjects With Moderate Atopic Dermatitis	Phase 2
Completed	`NCT04800185` - Characterizing Skin Microbiome Change in Atopic Dermatitis	Early Phase 1
Completed	`NCT06361992` - Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children	Phase 3
Recruiting	`NCT06024499` - Phase 2 Trial of HY209gel in Atopic Dermatitis Patients	Phase 2
Recruiting	`NCT03742414` - Seal, Stopping Eczema and Allergy Study	Phase 3
Completed	`NCT03090178` - Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy	N/A
Recruiting	`NCT05935085` - This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).	Phase 2
Recruiting	`NCT03795506` - TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)	N/A
Completed	`NCT01931644` - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed	`NCT04773587` - Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis	Phase 3
Active, not recruiting	`NCT04017520` - Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time